PPM1D and neoplasm: Inhibiting WIP1 or miR-21 by their inhibitor-laden nanoparticles both significantly inhibited the mammary tumor growth with ~60% of reduction in tumor volumes and ~50% of reduction in tumor weights (Fig. 8c–e).